Improve International Ltd. has been acquired by RJD Partners
Benchmark Holdings Plc. has sold Improve International Ltd. to RJD Partners.
Improve International provides both specialist postgraduate courses and qualifications as well as continuing professional development training to veterinary professionals. Its key programs are structured on a modular basis comprising both face-to-face practical and classroom learning as well as online delivery. With offices in the UK and Portugal, the business has global operations across the US, Australia and Japan. Courses are also available in multiple languages.
Founded in 2000, RJD Parters is an equity investor specializing in buy-outs, buy-ins and development capital for deals worth up to US$60 million.
Benchmark Holdings develops products and solutions in genetics, health and nutrition that improve performance, animal health and welfare, and reduce environmental impact across the aquaculture production cycle.
Oaklins Cavendish, based in the UK, advised the seller on this transaction.
James Banfield
Head of Knowledge Services, Benchmark Holdings Plc.
Contáctese con el equipo de la transacción
Transacciones relacionadas
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Ver másMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Ver másQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Ver más